Stroke or Transient Ischemic Attack in Patients With Transvenous Pacemaker or Defibrillator and Echocardiographically Detected Patent Foramen Ovale
Author(s) -
Christopher V. DeSimone,
Paul A. Friedman,
Amit Noheria,
Nikhil A. Patel,
Daniel C. DeSimone,
Sami Bdeir,
Christopher A. Aakre,
Vaibhav R. Vaidya,
Joshua P. Slusser,
David O. Hodge,
Michael J. Ackerman,
Alejandro A. Rabinstein,
Samuel J. Asirvatham
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.003540
Subject(s) - medicine , patent foramen ovale , hazard ratio , cardiology , stroke (engine) , confidence interval , atrial fibrillation , aspirin , warfarin , clinical endpoint , etiology , proportional hazards model , randomized controlled trial , migraine , mechanical engineering , engineering
A patent foramen ovale (PFO) may permit arterial embolization of thrombi that accumulate on the leads of cardiac implantable electronic devices in the right-sided cardiac chambers. We sought to determine whether a PFO increases the risk of stroke/transient ischemic attack (TIA) in patients with endocardial leads.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom